A pilot study involving 9 patients using MiniMed’s continuous glucose monitoring system shows a 1 percentage point drop in HbA1c values after 5 weeks.
The system is worn for 72 hours. It measures glucose levels every 10 seconds, averages readings over 5 minutes and stores 288 glucose measurements over a 24-hour period. The information gathered by the system allows physicians to make more precise adjustments to a patient’s diabetes treatment. The pilot study, conducted by Bruce W Bode, MD, was published in a recent issue of Diabetes Research and Clinical Practice.
“A 1% reduction [in HbA1c values] will significantly reduce the risk of … complications and prolong the patient’s life,” said Bode. “I have never seen so quick a reduction of HbA1c in any prior study, and these results demonstrate the benefits of continuous monitoring.”
Bode says the same improvements would not have been possible via conventional glucose meters.
Terence H. Gregg, MiniMed’s president and chief operating officer, says the continuous glucose monitoring system is still being refined.
“We have substantially improved the manufacturing process in terms of uniformity, are progressing on a telemetered patient version of the device and are making important advances on our sensor calibration efforts that are designed to improve patient convenience,” says Gregg.